CM
QDEL icon

CastleKnight Management’s QuidelOrtho QDEL Stock Holding History

CastleKnight Management’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,100
Closed -$418K – 270
2021
Q4 		$418K Buy
+3,100
New +$431K 0.09% 133

Other funds holding QDEL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

CastleKnight Management's QDEL Position: Q1 2022 in Review

CastleKnight Management sold out of QuidelOrtho (QDEL) in Q1 2022, closing a stake of 3,100 shares — an estimated $418K sold.

CastleKnight Management first reported a position in QDEL in Q4 2021 and held it in 1 quarter. The position peaked at $418K in Q4 2021. 354 funds tracked by Wall St. Rank hold QDEL as of Q1 2022.

  • CastleKnight Management reported no remaining QuidelOrtho position as of Q1 2022 after selling out during the quarter.
  • CastleKnight Management sold 3,100 QuidelOrtho shares in Q1 2022, an estimated $418K.
  • CastleKnight Management first reported a position in QuidelOrtho in Q4 2021 and held it in 1 quarter.
  • CastleKnight Management's QuidelOrtho position peaked at $418K in Q4 2021.
  • 354 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2022.

Based on CastleKnight Management's 13F filing for Q1 2022, filed 16 May 2022.